GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

GeneFerm Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	281.97	280.26	122.45	120.15	100.69	539.61
Cash & Short-Term Investments	281.97	280.26	122.45	120.15	100.69	539.61
Cash Growth	17.03%	128.88%	1.91%	19.33%	-81.34%	55.05%
Accounts Receivable	77.1	97.93	101.56	117.6	120.98	104.66
Other Receivables	1.36	15.83	15.22	0.15	0.46	0.24
Receivables	78.46	113.76	116.78	117.75	121.44	104.9
Inventory	213.94	190.23	165.87	155.43	142.61	114.83
Prepaid Expenses	-	-	-	3.8	8.81	5.84
Other Current Assets	12.5	11.23	6.87	-	-	-
Total Current Assets	586.87	595.48	411.97	397.13	373.54	765.18
Property, Plant & Equipment	658.82	663.58	708.46	761.95	734.28	510.39
Other Intangible Assets	0.89	1.16	1.7	2.02	1.1	1.4
Long-Term Deferred Tax Assets	11.22	9.88	14.37	8.87	8.66	7.7
Other Long-Term Assets	8.42	10.55	9.99	5.41	72.05	32.22
Total Assets	1,266	1,281	1,146	1,175	1,190	1,317

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	28.84	16.15	23.77	33.2	49.93	39.08
Accrued Expenses	46.11	54.28	46.71	58.39	51.9	40.95
Short-Term Debt	-	-	-	40	45	-
Current Portion of Long-Term Debt	33.16	33.16	24.43	5.25	26	308.65
Current Portion of Leases	6.88	6.26	5.42	6.04	5.97	5.19
Current Income Taxes Payable	-	1.82	-	19.01	10.28	13.42
Current Unearned Revenue	19.05	23.95	12.49	5.78	7.63	8.29
Other Current Liabilities	54.01	23.04	21.43	22.18	42.52	15.6
Total Current Liabilities	188.05	158.64	134.26	189.86	239.22	431.18
Long-Term Debt	188.8	205.38	126.54	-	5.25	31.25
Long-Term Leases	83.58	79.44	78.53	76.15	98.8	92.13
Pension & Post-Retirement Benefits	21.15	20.53	18.88	16.52	15.59	14.66
Long-Term Deferred Tax Liabilities	0.73	0.01	0.1	-	-	-
Other Long-Term Liabilities	0.01	0.01	0.01	0.01	0.01	0.01
Total Liabilities	482.31	464	358.31	282.54	358.86	569.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	414.6	414.6	414.6	414.6	414.6	407.89
Additional Paid-In Capital	294.34	294.34	294.34	294.34	294.34	270.69
Retained Earnings	76.4	109.84	81.38	186.69	124.26	72.27
Comprehensive Income & Other	-1.42	-2.11	-2.13	-2.79	-2.43	-3.19
Shareholders' Equity	783.91	816.66	788.18	892.84	830.77	747.66
Total Liabilities & Equity	1,266	1,281	1,146	1,175	1,190	1,317

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	312.42	324.23	234.92	127.44	181.02	437.22
Net Cash (Debt)	-30.45	-43.97	-112.47	-7.29	-80.33	102.39
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.73	-1.06	-2.71	-0.18	-1.89	2.21
Filing Date Shares Outstanding	41.46	41.46	41.46	41.46	41.46	40.79
Total Common Shares Outstanding	41.46	41.46	41.46	41.46	41.46	40.79
Working Capital	398.82	436.85	277.71	207.27	134.32	334
Book Value Per Share	18.91	19.70	19.01	21.53	20.04	18.33
Tangible Book Value	783.03	815.5	786.48	890.82	829.67	746.27
Tangible Book Value Per Share	18.89	19.67	18.97	21.49	20.01	18.30
Land	15.44	15.44	15.44	15.44	15.44	15.44
Buildings	457.57	457.57	457.26	260.87	259.44	255.46
Machinery	847.16	837.21	825.29	822.26	725.62	536.67
Construction In Progress	6.27	-	-	194.02	184.12	127.34

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error